Status:
COMPLETED
Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants
Lead Sponsor:
Novartis
Conditions:
Renal Transplantation
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
This extension study is considered to allow patients being treated with EC-MPS to collect further information on the long-term safety of this drug.
Eligibility Criteria
Inclusion
- Inclusion/ Exclusion criteria
- \- All patients who completed study CERL080A2405-DE01 and who are willing to continue treatment with EC-MPS.
- Other protocol-defined inclusion/exclusion criteria may apply.
Exclusion
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2005
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT00238940
Start Date
February 1 2003
End Date
September 1 2005
Last Update
January 31 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.